Tumor Cellular and Microenvironmental Cues Controlling Invadopodia Formation.

cell invasion cytoskeleton extracellular matrix invadopodia metastasis receptors tumor microenvironment

Journal

Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250

Informations de publication

Date de publication:
2020
Historique:
received: 16 07 2020
accepted: 09 09 2020
entrez: 12 11 2020
pubmed: 13 11 2020
medline: 13 11 2020
Statut: epublish

Résumé

During the metastatic progression, invading cells might achieve degradation and subsequent invasion into the extracellular matrix (ECM) and the underlying vasculature using invadopodia, F-actin-based and force-supporting protrusive membrane structures, operating focalized proteolysis. Their formation is a dynamic process requiring the combined and synergistic activity of ECM-modifying proteins with cellular receptors, and the interplay with factors from the tumor microenvironment (TME). Significant advances have been made in understanding how invadopodia are assembled and how they progress in degradative protrusions, as well as their disassembly, and the cooperation between cellular signals and ECM conditions governing invadopodia formation and activity, holding promise to translation into the identification of molecular targets for therapeutic interventions. These findings have revealed the existence of biochemical and mechanical interactions not only between the actin cores of invadopodia and specific intracellular structures, including the cell nucleus, the microtubular network, and vesicular trafficking players, but also with elements of the TME, such as stromal cells, ECM components, mechanical forces, and metabolic conditions. These interactions reflect the complexity and intricate regulation of invadopodia and suggest that many aspects of their formation and function remain to be determined. In this review, we will provide a brief description of invadopodia and tackle the most recent findings on their regulation by cellular signaling as well as by inputs from the TME. The identification and interplay between these inputs will offer a deeper mechanistic understanding of cell invasion during the metastatic process and will help the development of more effective therapeutic strategies.

Identifiants

pubmed: 33178698
doi: 10.3389/fcell.2020.584181
pmc: PMC7593604
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

584181

Informations de copyright

Copyright © 2020 Masi, Caprara, Bagnato and Rosanò.

Références

Sci Adv. 2020 Mar 11;6(11):eaax6912
pubmed: 32195338
Nat Rev Mol Cell Biol. 2018 Jul;19(7):419-435
pubmed: 29643418
Semin Immunol. 2003 Feb;15(1):49-55
pubmed: 12495640
Biophys J. 2018 Mar 27;114(6):1455-1466
pubmed: 29590602
Oncogene. 2017 Nov 23;36(47):6605-6616
pubmed: 28783171
Biochem Biophys Res Commun. 2020 Feb 19;522(4):1009-1014
pubmed: 31813546
Cancer Cell. 2019 Mar 18;35(3):347-367
pubmed: 30889378
Cancer Lett. 2018 Apr 10;419:245-256
pubmed: 29374558
Open Biol. 2013 Jun 05;3(6):120159
pubmed: 23740575
J Cell Biol. 2015 Feb 2;208(3):331-50
pubmed: 25646088
Cancer Res. 2010 Jun 1;70(11):4634-43
pubmed: 20484039
Carcinogenesis. 2014 Nov;35(11):2425-35
pubmed: 24970760
EBioMedicine. 2019 Sep;47:208-220
pubmed: 31420300
Cell. 2017 Feb 9;168(4):670-691
pubmed: 28187288
Mol Cancer Res. 2018 Oct;16(10):1601-1613
pubmed: 29866927
Pharmacol Rev. 2017 Jul;69(3):256-297
pubmed: 28626043
J Cell Sci. 2020 May 14;133(9):
pubmed: 32205364
Eur J Cell Biol. 2014 Oct;93(10-12):438-44
pubmed: 25113547
Eur J Cell Biol. 2011 Feb-Mar;90(2-3):115-27
pubmed: 20609496
J Biol Chem. 2013 Sep 6;288(36):26089-104
pubmed: 23888049
Biochim Biophys Acta Rev Cancer. 2018 Dec;1870(2):207-228
pubmed: 30316942
Cancer Res. 2020 Apr 1;80(7):1461-1474
pubmed: 32029550
Sci Rep. 2018 Jul 5;8(1):10191
pubmed: 29976963
J Cell Sci. 2010 Nov 1;123(Pt 21):3662-73
pubmed: 20971703
J Biol Chem. 1998 Jan 2;273(1):9-12
pubmed: 9417037
PLoS One. 2013 Sep 24;8(9):e75113
pubmed: 24086451
PLoS One. 2011;6(12):e28851
pubmed: 22216126
Eur J Cell Biol. 2011 Feb-Mar;90(2-3):128-35
pubmed: 20970878
PLoS One. 2012;7(1):e30219
pubmed: 22291919
Theranostics. 2019 Jan 1;9(2):324-336
pubmed: 30809277
J Cell Biol. 2010 May 3;189(3):541-56
pubmed: 20421424
J Cell Biol. 2012 Apr 30;197(3):421-37
pubmed: 22529104
Int J Mol Sci. 2019 Jun 04;20(11):
pubmed: 31167468
J Biol Chem. 2018 Jun 29;293(26):10172-10185
pubmed: 29752407
Cell Signal. 2009 Jul;21(7):1045-53
pubmed: 19249352
Nat Med. 2013 Nov;19(11):1423-37
pubmed: 24202395
Nat Commun. 2018 Oct 8;9(1):4144
pubmed: 30297715
Sci Rep. 2015 Mar 30;5:9466
pubmed: 25820462
Biophys J. 2011 Feb 2;100(3):573-582
pubmed: 21281571
Biochem Biophys Rep. 2016 Nov 09;9:13-21
pubmed: 28955984
Biol Open. 2012 Aug 15;1(8):711-22
pubmed: 23213464
J Cell Biol. 2013 Apr 15;201(2):279-92
pubmed: 23589494
Eur J Cell Biol. 2006 Apr;85(3-4):213-8
pubmed: 16546563
Tumour Biol. 2016 May;37(5):6775-85
pubmed: 26662305
J Biol Chem. 2020 Jul 31;295(31):10535-10559
pubmed: 32299913
Cancer Res. 2009 Feb 1;69(3):747-52
pubmed: 19141649
Nat Commun. 2017 Apr 24;8:15059
pubmed: 28436416
Nat Rev Cancer. 2013 Sep;13(9):637-51
pubmed: 23884378
Biophys J. 2014 Dec 2;107(11):2528-37
pubmed: 25468332
Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):4892-7
pubmed: 22411794
Sci Rep. 2016 Nov 30;6:37874
pubmed: 27901093
J Cell Sci. 2014 Apr 15;127(Pt 8):1712-25
pubmed: 24496451
Cancer Cell. 2012 Mar 20;21(3):309-22
pubmed: 22439926
J Biol Chem. 1996 Nov 1;271(44):27221-4
pubmed: 8910291
Oncotarget. 2016 Jul 26;7(30):47904-47917
pubmed: 27323814
Matrix Biol. 2020 Jan;85-86:80-93
pubmed: 31323325
J Cell Biol. 2014 Nov 24;207(4):517-33
pubmed: 25422375
Front Oncol. 2020 Feb 26;10:239
pubmed: 32175281
Int Rev Cell Mol Biol. 2019;346:129-155
pubmed: 31122393
J Cell Sci. 2019 Oct 18;132(20):
pubmed: 31533971
Trends Cell Biol. 2013 Jan;23(1):16-21
pubmed: 22999190
PLoS Biol. 2014 Nov 11;12(11):e1001995
pubmed: 25386698
Eur J Histochem. 2016 Dec 09;60(4):2728
pubmed: 28076931
Exp Cell Res. 2020 Apr 1;389(1):111893
pubmed: 32035133
PLoS Genet. 2016 Jan 14;12(1):e1005786
pubmed: 26765257
J Cell Biol. 2012 Aug 20;198(4):657-76
pubmed: 22908313
Rep Prog Phys. 2019 Jun;82(6):064602
pubmed: 30947151
J Exp Clin Cancer Res. 2019 Jun 14;38(1):258
pubmed: 31200779
J Clin Invest. 2013 May;123(5):2078-93
pubmed: 23563312
Trends Cell Biol. 2018 Feb;28(2):79-98
pubmed: 29162307
J Biol Chem. 2010 Dec 17;285(51):40201-11
pubmed: 20937825
J Cell Sci. 2017 Mar 15;130(6):1064-1077
pubmed: 28202690
J Cell Biol. 2008 Jun 16;181(6):985-98
pubmed: 18541705
Oncotarget. 2017 May 30;8(22):36099-36114
pubmed: 28415608
Cell Death Dis. 2018 Feb 20;9(3):292
pubmed: 29463791
Oncogene. 2016 Jun 30;35(26):3432-42
pubmed: 26522724
J Cell Biol. 2014 Jun 9;205(5):737-51
pubmed: 24891603
Exp Cell Res. 2011 Jan 15;317(2):195-209
pubmed: 20951132
Oncogene. 2019 May;38(19):3598-3615
pubmed: 30651600
Nat Commun. 2019 Oct 25;10(1):4886
pubmed: 31653854
J Cell Sci. 2012 Jun 15;125(Pt 12):2940-53
pubmed: 22366451
Mol Biol Cell. 2012 Jan;23(2):297-309
pubmed: 22114353
PLoS One. 2017 Aug 2;12(8):e0181579
pubmed: 28767724
J Biol Chem. 2016 Feb 26;291(9):4323-33
pubmed: 26740622
Cell Signal. 2016 Mar;28(3):165-176
pubmed: 26721186
FEBS Lett. 2008 Jun 18;582(14):2102-11
pubmed: 18396168
J Cell Biol. 2017 Dec 4;216(12):4331-4349
pubmed: 29061650
J Cell Biol. 2014 Nov 24;207(4):535-48
pubmed: 25404747
J Biol Chem. 2009 Oct 2;284(40):27315-26
pubmed: 19654316
Oncotarget. 2015 Oct 6;6(30):28519-20
pubmed: 26418722
Matrix Biol. 2017 Jan;57-58:190-203
pubmed: 27392543
J Cell Biochem. 2009 Dec 15;108(6):1252-62
pubmed: 19862699
Cancer Res. 2006 Mar 15;66(6):3034-43
pubmed: 16540652
Cell. 2011 Jun 24;145(7):1012-22
pubmed: 21703446
J Biol Chem. 2002 Apr 12;277(15):12487-90
pubmed: 11839732
J Cell Biol. 2005 Jan 31;168(3):441-52
pubmed: 15684033
Matrix Biol. 2019 Aug;81:17-33
pubmed: 30367951
Cancers (Basel). 2019 May 02;11(5):
pubmed: 31052560
Cell Calcium. 2020 Sep;90:102251
pubmed: 32683175
Oncogene. 2014 Mar 6;33(10):1265-73
pubmed: 23524582
Exp Cell Res. 2011 Nov 1;317(18):2562-72
pubmed: 21924264
Mol Cell. 2000 Dec;6(6):1425-36
pubmed: 11163215
Cancer Res. 2013 Oct 15;73(20):6175-84
pubmed: 23966293
J Cell Biol. 2010 Jan 11;188(1):11-9
pubmed: 19951899
Nat Cell Biol. 2015 Mar;17(3):350
pubmed: 25720965
J Cell Physiol. 1998 Jul;176(1):206-15
pubmed: 9618160
Oncogene. 2014 Aug 14;33(33):4203-12
pubmed: 24056963
Mol Biol Cell. 2013 Jun;24(11):1661-75, S1-11
pubmed: 23552693
Eur J Cell Biol. 2016 Nov;95(11):441-448
pubmed: 27402208
PLoS One. 2011 Feb 17;6(2):e17277
pubmed: 21359145
Front Pharmacol. 2019 Feb 19;10:125
pubmed: 30837883
Sci Signal. 2014 Nov 25;7(353):ra112
pubmed: 25429076
Cell Commun Signal. 2020 Apr 7;18(1):59
pubmed: 32264958
Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):3132-3137
pubmed: 29439204
J Cell Sci. 2016 May 1;129(9):1759-68
pubmed: 27029343
J Cell Sci. 2019 Mar 25;132(6):
pubmed: 30814332
Mol Cancer. 2012 Sep 11;11:65
pubmed: 22966858
Mol Cancer. 2018 Feb 19;17(1):58
pubmed: 29455648
Oncotarget. 2016 Dec 27;7(52):87037-87051
pubmed: 27888616
Oncogene. 2017 Nov 9;36(45):6244-6261
pubmed: 28692057
J Cell Biol. 2008 Mar 10;180(5):957-71
pubmed: 18332219
Exp Cell Res. 2008 Nov 15;314(19):3478-93
pubmed: 18848540
Cell Rep. 2013 Dec 12;5(5):1159-68
pubmed: 24290760
J Cell Sci. 2016 Oct 1;129(19):3661-3674
pubmed: 27694340
Cell Adh Migr. 2014;8(3):280-92
pubmed: 24840388
J Cell Biol. 2018 Feb 5;217(2):447-457
pubmed: 29233866
Prog Mol Biol Transl Sci. 2013;118:205-22
pubmed: 23764055
J Cell Sci. 2013 Nov 1;126(Pt 21):4835-42
pubmed: 23902689
Oncotarget. 2016 Dec 13;7(50):83684-83700
pubmed: 27845909
Cancer Res. 2011 Mar 1;71(5):1730-41
pubmed: 21257711
Nat Cell Biol. 2016 Apr;18(4):356-65
pubmed: 27027486
Proc Natl Acad Sci U S A. 2012 Nov 20;109(47):19280-5
pubmed: 23129656
J Cell Biol. 2009 Aug 24;186(4):571-87
pubmed: 19704022
Eur J Cell Biol. 2012 Nov-Dec;91(11-12):978-87
pubmed: 22717125
Annu Rev Cell Dev Biol. 2011;27:185-211
pubmed: 21801014
Nat Rev Cancer. 2003 Dec;3(12):921-30
pubmed: 14737122
Cancer Cell. 2011 Mar 8;19(3):372-86
pubmed: 21397860
Curr Opin Cell Biol. 2015 Oct;36:23-31
pubmed: 26186729
Curr Biol. 2011 Apr 26;21(8):635-44
pubmed: 21474314
Cancer Sci. 2010 May;101(5):1133-40
pubmed: 20219074
J Cell Sci. 2009 Sep 1;122(Pt 17):3037-49
pubmed: 19692590
Cancer Lett. 2015 Jan 28;356(2 Pt B):382-91
pubmed: 25451317
Cell. 2016 Jun 30;166(1):21-45
pubmed: 27368099
Oncogene. 2014 Jul 17;33(29):3784-93
pubmed: 24013225
J Dermatol Sci. 2017 Jul;87(1):29-35
pubmed: 28381343
Cytoskeleton (Hoboken). 2013 Oct;70(10):572-89
pubmed: 23804547
FASEB J. 2010 Oct;24(10):3903-15
pubmed: 20547664
Nat Commun. 2018 Jun 22;9(1):2443
pubmed: 29934494
Annu Rev Cell Dev Biol. 2016 Oct 6;32:555-576
pubmed: 27501444
J Physiol. 2017 May 15;595(10):3063-3075
pubmed: 28304082
Oncol Rep. 2014 Feb;31(2):940-6
pubmed: 24337203
Curr Biol. 2008 Sep 9;18(17):1295-1299
pubmed: 18718759
J Exp Clin Cancer Res. 2016 Jul 29;35(1):121
pubmed: 27473335
Cell Rep. 2014 Sep 11;8(5):1558-70
pubmed: 25176655
Genes Cells. 2003 Dec;8(12):1019-27
pubmed: 14750956
Mol Biol Cell. 2017 May 15;28(10):1347-1360
pubmed: 28356423
J Cell Sci. 2017 Jun 1;130(11):1965-1978
pubmed: 28446539
Cancer Lett. 2020 Jul 28;483:98-113
pubmed: 32217106
Exp Mol Pathol. 2019 Feb;106:17-26
pubmed: 30439350
PLoS One. 2013;8(2):e55529
pubmed: 23405166
J Cell Biol. 2011 Nov 28;195(5):903-20
pubmed: 22105349
Trends Cell Biol. 2017 Aug;27(8):595-607
pubmed: 28412099
Curr Biol. 2013 Nov 4;23(21):2079-89
pubmed: 24206842

Auteurs

Ilenia Masi (I)

Unit of Preclinical Models and New Therapeutic Agents, IRCCS - Regina Elena National Cancer Institute, Rome, Italy.

Valentina Caprara (V)

Unit of Preclinical Models and New Therapeutic Agents, IRCCS - Regina Elena National Cancer Institute, Rome, Italy.

Anna Bagnato (A)

Unit of Preclinical Models and New Therapeutic Agents, IRCCS - Regina Elena National Cancer Institute, Rome, Italy.

Laura Rosanò (L)

Unit of Preclinical Models and New Therapeutic Agents, IRCCS - Regina Elena National Cancer Institute, Rome, Italy.
Institute of Molecular Biology and Pathology, CNR, Rome, Italy.

Classifications MeSH